REQUEST A DEMO
Total
USD $0.00
Search more companies

Fifarma S.A.S (Colombia)

Main Activities: Research and Development in the Social Sciences and Humanities
Full name: Fifarma S.A.S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fifarma S.A.S is an enterprise located in Colombia, with the main office in Bogota D.C.. The company operates in the Research and Development in the Social Sciences and Humanities sector. The company was established on March 20, 2018. It currently has a total number of 4 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 42.53% in 2023. Its’ total assets recorded a growth of 56.07%. The net profit margin of Fifarma S.A.S increased by 2.41% in 2023.

Headquarters
Cr 14 # 99 33 Of 602
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Fifarma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Fifarma S.A.S report to view the information.
Outstanding Shares:
Purchase the Fifarma S.A.S report to view the information.
Incorporation Date:
March 20, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Fifarma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
42.53%
Total operating revenue
42.53%
Operating profit (EBIT)
5906.86%
Net Profit (Loss) for the Period
3264.88%
Total assets
56.07%
Total equity
94.74%
Operating Profit Margin (ROS)
11.51%
Net Profit Margin
2.41%
Return on Equity (ROE)
45.83%
Quick Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?